Giembycz M A, Diamond J
Division of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
Biochem Pharmacol. 1990 Jan 15;39(2):271-83. doi: 10.1016/0006-2952(90)90026-h.
In the search for a phosphate acceptor to estimate cyclic AMP-dependent protein kinase (A-kinase) activity in respiratory tissues devoid of the disadvantages inherent with the use of histones, we compared and contrasted a conventional substrate, histone IIa, with that of a novel heptapeptide phosphate acceptor, Kemptide (Kemp et al., J Biol Chem 252: 4888-4894, 1977). The specific activities of soluble A-kinase isolated from guinea-pig lung parenchyma and from bovine tracheal smooth muscle were significantly (12-16-fold) greater when Kemptide was used as substrate when compared to histone IIa. Moreover, studies with a specific inhibitor of A-kinase demonstrated that whilst the cyclic AMP-stimulated phosphorylation of Kemptide was catalysed exclusively by A-kinase, only approximately 89% of the phosphate incorporated into histone IIa was attributed to the activity of this enzyme. The activation constant (Kact) of cyclic AMP for A-kinase was estimated to be 1.5 microM when Kemptide was used as substrate, 25-fold higher than that obtained using histone IIa (60 nM) under identical conditions. In a complementary series of experiments it was found that both the basal and isoprenaline-stimulated A-kinase activity ratios were significantly higher when histone IIa was used as substrate when compared with that obtained using Kemptide. Elevating the ionic strength of the homogenization buffer or assay cocktail with NaCl produced a reversible (following dialysis), concentration-dependent, mixed uncompetitive, inhibition of cyclic AMP-stimulated histone phosphorylation; phosphokemptide formation was unaffected. The ability of salt to inhibit A-kinase activity also affected the elution profile of A-kinase isoenzymes following their separation by DEAE-cellulose chromatography. With histone IIa as substrate the Type I:Type II isoenzyme ratio in guinea-pig lung and in bovine tracheal smooth muscle was 9:91 and 35:65, respectively. Changing the phosphate acceptor to Kemptide reduced these respective ratios to 5:95 and 29:71. Although the effect on the isoenzyme ratio was small, the specific activities of the two isoenzymes isolated from both tissues were markedly attentuated by ca. 9% (Type I) and 36% (Type II). It is concluded that Kemptide is without many of the disadvantages inherent with histone IIa and is, thus, a preferable phosphate acceptor for estimating soluble A-kinase activity and determining the isoenzyme ratio in guinea-pig lung and in bovine tracheal smooth muscle.
为了寻找一种磷酸受体来评估呼吸组织中环磷酸腺苷依赖性蛋白激酶(A激酶)的活性,以避免使用组蛋白所固有的缺点,我们对传统底物组蛋白IIa与新型七肽磷酸受体肯普肽(Kemp等人,《生物化学杂志》252:4888 - 4894,1977)进行了比较和对比。与组蛋白IIa相比,当使用肯普肽作为底物时,从豚鼠肺实质和牛气管平滑肌中分离出的可溶性A激酶的比活性显著更高(12 - 16倍)。此外,用A激酶的特异性抑制剂进行的研究表明,虽然肯普肽的环磷酸腺苷刺激的磷酸化仅由A激酶催化,但掺入组蛋白IIa中的磷酸只有约89%归因于该酶的活性。当使用肯普肽作为底物时,环磷酸腺苷对A激酶的活化常数(Kact)估计为1.5微摩尔,比在相同条件下使用组蛋白IIa(60纳摩尔)时高25倍。在一系列补充实验中发现,与使用肯普肽相比,当使用组蛋白IIa作为底物时,基础和异丙肾上腺素刺激的A激酶活性比均显著更高。用氯化钠提高匀浆缓冲液或测定混合液的离子强度会产生可逆的(透析后)、浓度依赖性的、混合型非竞争性的环磷酸腺苷刺激的组蛋白磷酸化抑制作用;磷酸肯普肽的形成不受影响。盐抑制A激酶活性的能力也影响了A激酶同工酶经DEAE - 纤维素色谱分离后的洗脱图谱。以组蛋白IIa作为底物时,豚鼠肺和牛气管平滑肌中I型:II型同工酶的比例分别为9:91和35:65。将磷酸受体改为肯普肽后,这些比例分别降至5:95和29:71。尽管对同工酶比例的影响较小,但从这两种组织中分离出的两种同工酶的比活性均明显降低,I型约降低9%,II型约降低36%。结论是,肯普肽没有组蛋白IIa所固有的许多缺点,因此,它是评估豚鼠肺和牛气管平滑肌中可溶性A激酶活性以及确定同工酶比例的更优磷酸受体。